Azione ABB AB-BIOTICS, S.A.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue AB-Biotics, S.A.

Azioni

ABB

ES0109659013

Prezzo di chiusura BME
Altri mercati azionari
 		Variaz. 5gg Var. 1 gen.
- EUR -.--% Grafico intraday di AB-Biotics, S.A. -.--% -.--%
2022 AB-Biotics, S.A. ha acquisito Alifarm S.A. per 3,5 milioni di euro. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million.
Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A.
Kaneka Europe Holding Company N.V. made an offer to acquire remaining 33.67% stake in AB-Biotics, S.A. for €21.2 million.
Kaneka Corporation has completed the voluntary offer to acquire an additional 26.57% stake in AB-Biotics, S.A. for €16.7 million.
Kaneka Corporation made a voluntary public offer to acquire the remaining 60.24% stake in AB-Biotics, S.A. for €37.9 million.
Ab-Biotics Sa Reports Earnings Results for the Full Year Ended December 31, 2018
Kaneka Corporation Concludes License Agreement with AB-Biotics for Production and Sales of its Probiotics Products
Kaneka Corporation completed the acquisition of 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
Kaneka Americas Holding Inc. enters into Licensing Agreement with AB-Biotics, S.A
Kaneka Corporation signed an agreement to acquire 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
Corporacion Ivamosa and Gestion Y Administracion Mobiliaria, S.A. acquired 10% stake in AB-Biotics, S.A..
Frutarom Industries Ltd. acquired AB-Fortis from AB-Biotics, S.A..
AB-Biotics SA announced a financing transaction
AB-Biotics Agrees Distribution Deal with Abbott for I3.1 Probiotic in Spain
DuPont Nutrition & Health and AB-Biotics Announce Agreement on Probiotic for Cardiovascular Health
AB-Biotics Provides Earnings Guidance for the Full Year of 2013
AB-Biotics SA sold Quantum Experimental S.L.
AB-Biotics and Scienta Farma Sign Distribution Agreement to Market Genetic Test Neurofarmagen in Mexico
AB-Biotics SA announced that it expects to receive €1.08 million in funding.
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione ABB
  4. Notizie AB-Biotics, S.A.
  5. Altre lingue